Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-020646
Filing Date
2023-12-15
Accepted
2023-12-15 18:16:13
Documents
1
Period of Report
2023-12-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5216
  Complete submission text file 0000899243-23-020646.txt   6657
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Issuer) CIK: 0001060736 (see all company filings)

EIN.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 21823 30TH DRIVE SE BOTHELL WA 98021
Business Address
ROMP CHARLES R (Reporting) CIK: 0001809717 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-32405 | Film No.: 231491732